Pharma CEO Mission Is Defined By Complexity, Products And Trust – Hassan
The explosion in pharmaceutical industry partnerships is one reason that managing "complexity" is a critical core competency for industry leaders, Schering-Plough CEO Fred Hassan told the Pharma, Biotech & Device Colloquium in Princeton, N.J. June 7
You may also be interested in...
Schering-Plough will retain an independent consultant to review its compliance with the Foreign Corrupt Practices Act as part of a $500,000 settlement with the Securities & Exchange Commission
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011